Total Payments
$14,458
2024 Payments
$1,551
Companies
36
Transactions
544
Medicare Patients
1,096
Medicare Billing
$72,846
Payment Breakdown by Category
Food & Beverage$13,647 (94.4%)
Consulting$800.00 (5.5%)
Education$11.71 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,647 | 542 | 94.4% |
| Consulting Fee | $800.00 | 1 | 5.5% |
| Education | $11.71 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,249 | 116 | $0 (2024) |
| Novo Nordisk Inc | $1,901 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,676 | 25 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,098 | 4 | $0 (2021) |
| Lilly USA, LLC | $977.34 | 44 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $884.31 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $637.35 | 18 | $0 (2024) |
| PFIZER INC. | $549.09 | 22 | $0 (2024) |
| Alkermes, Inc. | $438.32 | 15 | $0 (2024) |
| GlaxoSmithKline, LLC. | $433.88 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,551 | 60 | AstraZeneca Pharmaceuticals LP ($423.00) |
| 2023 | $5,481 | 251 | ABBVIE INC. ($785.99) |
| 2022 | $4,069 | 192 | Novo Nordisk Inc ($620.67) |
| 2021 | $3,358 | 41 | Biohaven Pharmaceuticals, Inc. ($1,098) |
All Payment Transactions
544 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $112.20 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $0.33 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/14/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $76.20 | General |
| Category: VACCINES | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $120.10 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $0.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Bone Health | ||||||
| 04/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Inflammation | ||||||
| 03/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Respiratory | ||||||
| 03/13/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: PSYCHIATRY | ||||||
| 03/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.35 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 241 | 359 | $46,886 | $16,988 |
| 2022 | 10 | 323 | 427 | $56,570 | $20,993 |
| 2021 | 9 | 280 | 353 | $52,824 | $20,521 |
| 2020 | 11 | 252 | 293 | $42,429 | $14,344 |
Total Patients
1,096
Total Services
1,432
Medicare Billing
$72,846
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 143 | $25,309 | $9,015 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 79 | $10,093 | $3,876 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $7,728 | $2,926 | 37.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $487.00 | $400.82 | 82.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 36 | $2,160 | $288.43 | 13.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 29 | $899.00 | $276.08 | 30.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 25 | 30 | $210.00 | $205.80 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 165 | $26,895 | $10,604 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 107 | $12,173 | $4,734 | 38.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $9,108 | $3,477 | 38.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $1,176 | $822.48 | 69.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $523.00 | $409.05 | 78.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 12 | 12 | $4,188 | $369.11 | 8.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 29 | $899.00 | $278.79 | 31.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 23 | $1,380 | $201.44 | 14.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 19 | 20 | $140.00 | $59.10 | 42.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 11 | 11 | $88.00 | $37.95 | 43.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 134 | $21,842 | $9,188 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 52 | 52 | $14,352 | $5,525 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 61 | $6,649 | $2,785 | 41.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 17 | 17 | $6,936 | $2,299 | 33.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 24 | 25 | $775.00 | $233.04 | 30.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 28 | $1,680 | $226.50 | 13.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $410.00 | $190.00 | 46.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 12 | $96.00 | $41.76 | 43.5% |
About Miranda Tedder
Miranda Tedder is a Family healthcare provider based in Kokomo, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2019. The National Provider Identifier (NPI) number assigned to this provider is 1023650868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Miranda Tedder has received a total of $14,458 in payments from pharmaceutical and medical device companies, with $1,551 received in 2024. These payments were reported across 544 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($13,647).
As a Medicare-enrolled provider, Tedder has provided services to 1,096 Medicare beneficiaries, totaling 1,432 services with total Medicare billing of $72,846. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Kokomo, IN
- Active Since 10/14/2019
- Last Updated 11/27/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1023650868
Products in Payments
- VRAYLAR (Drug) $1,391
- NURTEC ODT (Drug) $1,351
- FARXIGA (Drug) $1,034
- Kerendia (Drug) $884.31
- JARDIANCE (Drug) $681.27
- MOUNJARO (Drug) $664.39
- Wegovy (Drug) $642.60
- UBRELVY (Drug) $620.73
- Rybelsus (Drug) $484.82
- CAPLYTA (Drug) $481.05
- NEXLIZET (Drug) $374.92
- BREZTRI (Drug) $356.82
- ARISTADA (Drug) $338.32
- REXULTI (Drug) $288.15
- AIRSUPRA (Drug) $269.01
- RYBELSUS (Drug) $267.02
- QUVIVIQ (Drug) $266.33
- Saxenda (Drug) $263.62
- AREXVY (Drug) $254.28
- Azstarys (Drug) $193.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Kokomo
Raymond Candelaria
Family — Payments: $6,971
Family $6,971
Jessie Myers, Fnp, FNP
Family — Payments: $6,207
Family $6,207
Amy Julian-Resner, Fnp-C, FNP-C
Family — Payments: $4,252
Family $4,252
Allison Cardwell
Family — Payments: $4,105
Family $4,105
Autumn Montgomery, Fnp-C, FNP-C
Family — Payments: $3,814
Family $3,814
Kelly Smith, Fnp-C, FNP-C
Family — Payments: $3,553
Family $3,553